Ecrg4 Attenuates the Inflammatory Proliferative Response of Mucosal Epithelial Cells to Infection

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Kurabi, Arwa ^a,b   Pak, Kwang ^a,b   Dang, Xitong ^a   Coimbra, Raul ^a   Eliceiri, Brian P ^a   Ryan, Allen F ^a,b   Baird, Andrew ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ESOPHAGEAL CANCER RELATED GENE 4 PROTEIN; MESSENGER RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ECRG4 PROTEIN, RAT; SERINE PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; ESOPHAGEAL CANCER RELATED GENE 4; GENE EXPRESSION; HAEMOPHILUS INFLUENZAE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE EAR MUCOSA; MUCOSA CELL; NONHUMAN; OTITIS MEDIA; RAT; TUMOR SUPPRESSOR GENE; ADENOVIRIDAE; ANIMAL; CELL MOTION; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HAEMOPHILUS INFECTION; IMMUNOLOGY; MICROBIOLOGY; MIDDLE EAR; MUCOSA; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADENOVIRIDAE;

ADENOVIRIDAE; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; EAR, MIDDLE; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GENETIC VECTORS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; MALE; MUCOUS MEMBRANE; OTITIS MEDIA; RATS; RATS, SPRAGUE-DAWLEY; SERINE PROTEASES; TRANSDUCTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 84876515399     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061394     Document Type: Article

References (46)

1. Kagnoff MF, Eckmann L, (1997) Epithelial cells as sensors for microbial infection. J Clin Invest 100: 6-10.
2. Holmgren J, Czerkinsky C, (2005) Mucosal immunity and vaccines. Nat Med 11: S45-53.
3. Gill N, Wlodarska M, Finlay BB, (2010) The future of mucosal immunology: studying an integrated system-wide organ. Nat Immunol 11: 558-560.
4. Beutler BA, (2009) TLRs and innate immunity. Blood 113: 1399-1407.
5. Istomin AY, Godzik A, (2009) Understanding diversity of human innate immunity receptors: analysis of surface features of leucine-rich repeat domains in NLRs and TLRs. BMC Immunol 10: 48.
6. Lavelle EC, Murphy C, O'Neill LA, Creagh EM, (2010) The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. Mucosal Immunol 3: 17-28.
7. Iwasaki A, Medzhitov R, (2010) Regulation of adaptive immunity by the innate immune system. Science 327: 291-295.
8. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, et al. (1997) Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88: 553-560.
9. Menendez A, Ferreira RB, Finlay BB, (2010) Defensins keep the peace too. Nat Immunol 11: 49-50.
10. Calandra T, (2003) Macrophage migration inhibitory factor and host innate immune responses to microbes. Scand J Infect Dis 35: 573-576.
11. Harris HE, Raucci A, (2006) Alarmin(g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep 7: 774-778.
12. Oppenheim JJ, Yang D, (2005) Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 17: 359-365.
13. Baird A, Coimbra R, Dang X, Lopez N, Lee J, et al. (2012) Cell surface localization and release of the candidate tumor suppressor Ecrg4 from polymorphonuclear cells and monocytes activate macrophages. J Leukoc Biol 91: 773-781.
14. Dang X, Podvin S, Coimbra R, Eliceiri B, Baird A, (2012) Cell-specific processing and release of the hormone-like precursor and candidate tumor suppressor gene product, Ecrg4. Cell Tissue Res 348: 505-514.
15. Podvin S, Gonzalez AM, Miller MC, Dang X, Botfield H, et al. (2011) Esophageal cancer related gene-4 is a choroid plexus-derived injury response gene: evidence for a biphasic response in early and late brain injury. PLoS One 6: e24609.
16. Shaterian A, Kao S, Chen L, Dipietro LA, Coimbra R, et al. (2012) The candidate tumor suppressor gene Ecrg4 as a wound terminating factor in cutaneous injury. Arch Dermatol Res.
17. Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, et al. (2003) The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res 13: 2265-2270.
18. Grimmond SM, Miranda KC, Yuan Z, Davis MJ, Hume DA, et al. (2003) The mouse secretome: functional classification of the proteins secreted into the extracellular environment. Genome Res 13: 1350-1359.
19. Mirabeau O, Perlas E, Severini C, Audero E, Gascuel O, et al. (2007) Identification of novel peptide hormones in the human proteome by hidden Markov model screening. Genome Res 17: 320-327.
20. Ozawa A, Lick AN, Lindberg I, (2011) Processing of proaugurin is required to suppress proliferation of tumor cell lines. Mol Endocrinol 25: 776-784.
21. Wang YB, Ba CF, (2012) Promoter Methylation of Esophageal Cancer-Related Gene 4 in Gastric Cancer Tissue and its Clinical Significance. Hepatogastroenterology 59.
22. Yue CM, Deng DJ, Bi MX, Guo LP, Lu SH, (2003) Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma. World J Gastroenterol 9: 1174-1178.
23. Gotze S, Feldhaus V, Traska T, Wolter M, Reifenberger G, et al. (2009) ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer 9: 447.
24. Li LW, Yu XY, Yang Y, Zhang CP, Guo LP, et al. (2009) Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo. Int J Cancer 125: 1505-1513.
25. Sabatier R, Finetti P, Adelaide J, Guille A, Borg JP, et al. (2011) Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer. PLoS One 6: e27656.
26. Li W, Liu X, Zhang B, Qi D, Zhang L, et al. (2010) Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion. J Exp Clin Cancer Res 29: 89.
27. Gonzalez AM, Podvin S, Lin SY, Miller MC, Botfield H, et al. (2011) Ecrg4 expression and its product augurin in the choroid plexus: impact on fetal brain development, cerebrospinal fluid homeostasis and neuroprogenitor cell response to CNS injury. Fluids Barriers CNS 8: 6.
28. Li L, Li Y, Li X, Zhang C, Zhou Y, et al. (2011) A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma. BMC Cancer 11: 52.
29. Palacios SD, Pak K, Kayali AG, Rivkin AZ, Aletsee C, et al. (2002) Participation of Ras and extracellular regulated kinase in the hyperplastic response of middle-ear mucosa during bacterial otitis media. J Infect Dis 186: 1761-1769.
30. Furukawa M, Ebmeyer J, Pak K, Austin DA, Melhus A, et al. (2007) Jun N-terminal protein kinase enhances middle ear mucosal proliferation during bacterial otitis media. Infect Immun 75: 2562-2571.
31. Ebmeyer J, Furukawa M, Pak K, Ebmeyer U, Sudhoff H, et al. (2005) Role of mast cells in otitis media. J Allergy Clin Immunol 116: 1129-1135.
32. Leichtle A, Hernandez M, Pak K, Webster NJ, Wasserman SI, et al. (2009) The toll-Like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery. BMC Immunol 10: 45.
33. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
34. Ebmeyer J, Leichtle A, Hernandez M, Ebmeyer U, Husseman J, et al. (2011) TNFA deletion alters apoptosis as well as caspase 3 and 4 expression during otitis media. BMC Immunol 12: 12.
35. Matsuzaki J, Torigoe T, Hirohashi Y, Kamiguchi K, Tamura Y, et al. (2012) ECRG4 is a negative regulator of caspase-8-mediated apoptosis in human T-leukemia cells. Carcinogenesis 33: 996-1003.
36. Hirano T, Kodama S, Fujita K, Maeda K, Suzuki M, (2007) Role of Toll-like receptor 4 in innate immune responses in a mouse model of acute otitis media. FEMS Immunol Med Microbiol 49: 75-83.
37. Husseman J, Palacios SD, Rivkin AZ, Oehl H, Ryan AF, (2012) The role of vascular endothelial growth factors and fibroblast growth factors in angiogenesis during otitis media. Audiol Neurootol 17: 148-154.
38. Palacios SD, Pak K, Rivkin AZ, Bennett T, Ryan AF, (2002) Growth factors and their receptors in the middle ear mucosa during otitis media. Laryngoscope 112: 420-423.
39. Leichtle A, Hernandez M, Lee J, Pak K, Webster NJ, et al. (2012) The role of DNA sensing and innate immune receptor TLR9 in otitis media. Innate Immun 18: 3-13.
40. Chai JY, Modak C, Mouazzen W, Narvaez R, Pham J, (2010) Epithelial or mesenchymal: Where to draw the line? Biosci Trends 4: 130-142.
41. Poeschla EM, Wong-Staal F, Looney DJ, (1998) Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 4: 354-357.
42. Palacios SD, Pak K, Rivkin AZ, Kayali AG, Austen D, et al. (2004) Role of p38 mitogen-activated protein kinase in middle ear mucosa hyperplasia during bacterial otitis media. Infect Immun 72: 4662-4667.
43. Ryan AF, Ebmeyer J, Furukawa M, Pak K, Melhus A, et al. (2006) Mouse models of induced otitis media. Brain Res 1091: 3-8.
44. Zheng QY, Hardisty-Hughes R, Brown SD, (2006) Mouse models as a tool to unravel the genetic basis for human otitis media. Brain Res 1091: 9-15.
45. Kujuro Y, Suzuki N, Kondo T, (2010) Esophageal cancer-related gene 4 is a secreted inducer of cell senescence expressed by aged CNS precursor cells. Proc Natl Acad Sci U S A 107: 8259-8264.
46. Mori Y, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, et al. (2007) Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Oncol Rep 18: 981-985.